Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Asker Healthcare Group AB ( (SE:ASKER) ) just unveiled an update.
Asker Healthcare Group has acquired InnoMedicus AG, a Swiss distributor specializing in diagnostic devices and minimally invasive therapies for urology. This acquisition is expected to enhance Asker’s service delivery to healthcare providers and patients across Europe, particularly in prostate cancer therapies, and contribute positively to the group’s EBITA margin.
The most recent analyst rating on (SE:ASKER) stock is a Hold with a SEK90.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare company that partners with caregivers and patients across Europe by providing medical products and solutions. The group focuses on improving patient outcomes, reducing the total cost of care, and ensuring a sustainable value chain. Asker combines the entrepreneurial drive of local companies with the capabilities of a large group, employing over 4,500 people across 19 countries with revenues amounting to SEK 16 billion.
Average Trading Volume: 1,139,104
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK33B
Find detailed analytics on ASKER stock on TipRanks’ Stock Analysis page.